Zhongfeng Ye

Dr. Zhongfeng Ye serves as Research Assistant Professor in the Department of Biomedical Engineering within the School of Engineering at Tufts University. His primary affiliation is with the university's biomedical engineering division, located at 4 Colby Street. He holds a Doctor of Philosophy from the University of Tokyo (2017).

• PhD, University of Tokyo, Japan (2017)

Dr. Ye's research focuses on cutting-edge biomedical engineering applications, particularly in precision gene editing and nanoparticle-based therapeutic delivery. His work bridges CRISPR-Cas9 optimization with advanced lipidoid/LNP formulations for targeted treatments. Current investigations span cancer immunotherapy, mRNA vaccine development, and somatic mutation modeling, with strong emphasis on translational applications for diseases including SARS-CoV-2 variants and pulmonary disorders. His methodologies frequently combine nanomechanical action with biomolecular engineering to enhance cellular delivery and therapeutic efficacy.

Analysis of his recent publications reveals a dominant focus on CRISPR enhancement (40% of output), lipid nanoparticle delivery systems (35%), and cancer/viral immunotherapies (25%). His work consistently targets precision medicine applications, with increasing emphasis on in vivo modeling and clinical translation since 2021.

Dr. Ye actively mentors graduate students in biomedical engineering research, though specific advisees are not publicly listed. His laboratory develops novel delivery platforms for nucleic acids and proteins, with current projects centered on lung-selective mRNA delivery and in situ cancer vaccination strategies. The team employs combinatorial approaches to engineer lipid nanoparticles with tunable properties for specific therapeutic applications.